文献速递心脏核医学骨显像与常规 SPECT放射性药物与辐射防护

心脏外放射性示踪剂生物分布对心脏淀粉样变性评估的作用:基于[99mTc]Tc-DPD与[99mTc]Tc-HMDP的回顾性多中心研究

The role of extracardiac radiotracer biodistribution in the evaluation of cardiac amyloidosis: a retrospective multicenter study on [99mTc]Tc-DPD and [99mTc]Tc-HMDP.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-10-23

该回顾性多中心研究纳入224例疑似心脏淀粉样变性患者,比较[99mTc]Tc-DPD与[99mTc]Tc-HMDP的诊断性能和全身生物分布。在ATTRwt中,DPD组以Perugini 2级为主(76%),HMDP组偏向3级(72%,p<0.001);DPD与附肢肌肉摄取显著相关,HMDP对肺滞留有独特倾向;内脏摄取在ATTR中罕见,是强烈提示AL淀粉样变性的阴性预测因子(OR 0.016,p<0.001)。结论认为两种示踪剂生物分布不同,不可直接互换。

要点

  • ATTRwt中DPD组以Perugini 2级为主(76%),HMDP组偏向3级(72%,p<0.001)。
  • DPD与附肢肌肉摄取显著相关(ATTRwt:84% vs 38%,p<0.001),形成软组织“竞争性摄取”。
  • HMDP对肺滞留有独特倾向(ATTRwt:68% vs 46%,p=0.008;ATTRv:61% vs 10%,p=0.006);内脏摄取强烈提示AL(OR 0.016,p<0.001)。

核心结论

  • [99mTc]Tc-DPD与[99mTc]Tc-HMDP具有不同的生物分布特征,不可直接互换。
  • HMDP可最大化心肌对比度,而DPD能更优反映全身肌肉骨骼淀粉样负荷。
  • 核医学医师需采用示踪剂特异性的判读方法以优化无创表型分析。

研究设计与样本

  • 回顾性多中心队列研究,纳入疑似心脏淀粉样变性并接受晚期平面全身显像及靶向SPECT/CT的患者。
  • 纳入要求最终确诊为ATTRwt、ATTRv或AL淀粉样变性,共224例(DPD组109例,HMDP组115例)。

主要发现

  • ATTRwt中,DPD组以Perugini 2级为主(76%),HMDP组偏向3级(72%,p<0.001)。
  • DPD与附肢肌肉摄取显著相关(ATTRwt:84% vs 38%,p<0.001),形成软组织“竞争性摄取”。
  • HMDP对肺滞留有独特倾向(ATTRwt:68% vs 46%,p=0.008;ATTRv:61% vs 10%,p=0.006)。
  • 内脏摄取在ATTR中罕见,是强烈提示AL淀粉样变性的阴性预测因子(OR 0.016,p<0.001)。

关键数值与推荐

  • ATTRwt中DPD组Perugini 2级占76%,HMDP组3级占72%(p<0.001)。
  • ATTRwt附肢肌肉摄取DPD组84% vs HMDP组38%(p<0.001)。
  • ATTRwt肺滞留HMDP组68% vs DPD组46%(p=0.008);ATTRv中HMDP组61% vs DPD组10%(p=0.006)。
  • 内脏摄取预测AL淀粉样变性的OR为0.016(p<0.001)。

临床怎么用

  • 解读[99mTc]Tc-DPD或[99mTc]Tc-HMDP显像时需考虑示踪剂特异性生物分布,避免直接互换判读标准。
  • HMDP更利于心肌对比度评估,DPD更适于观察全身肌肉骨骼淀粉样负荷。
  • 内脏摄取罕见时强烈提示AL淀粉样变性,应结合临床进一步鉴别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bone scintigraphy using [99mTc]Tc-DPD or [99mTc]Tc-HMDP is a non-invasive cornerstone for diagnosing transthyretin cardiac amyloidosis (ATTR-CA). However, their interchangeability and the clinical relevance of systemic extracardiac uptake (ExtCU) remain poorly defined. AIM: To systematically compare the diagnostic performance and whole-body biodistribution profiles of [99mTc]Tc-DPD and [99mTc]Tc-HMDP in patients with suspected cardiac amyloidosis (CA). METHODS: We retrospectively evaluated a multicenter cohort of patients investigated for suspected CA who underwent late planar whole-body scintigraphy and targeted SPECT/CT with either radiotracer as part of their diagnostic workup. Inclusion required a final, confirmed diagnosis of ATTRwt, ATTRv, or AL amyloidosis. Myocardial visual Perugini score (VISUAL_PS) and systemic ExtCU (pulmonary, appendicular muscular, visceral, and miscellaneous) were recorded. RESULTS: The study included 224 patients (DPD: n = 109, comprising 70 ATTRwt, 20 ATTRv, 19 AL; HMDP: n = 115, comprising 90 ATTRwt, 13 ATTRv, 12 AL). In ATTRwt, the DPD cohort presented predominantly with Perugini Grade 2 (76%), whereas the HMDP cohort skewed toward Grade 3 (72%, p < 0.001). DPD was significantly associated with appendicular muscular uptake (ATTRwt: 84% vs. 38%, p < 0.001), creating a competitive "soft-tissue sink effect". Conversely, HMDP demonstrated a unique predilection for pulmonary retention (ATTRwt: 68% vs. 46%, p = 0.008; ATTRv: 61% vs. 10%, p = 0.006). Visceral uptake was rare in ATTR but was a robust negative predictor strongly favoring AL amyloidosis (OR 0.016, p < 0.001). CONCLUSIONS: [99mTc]Tc-DPD and [99mTc]Tc-HMDP possess distinct biodistribution profiles precluding direct interchangeability. HMDP maximizes myocardial contrast, whereas DPD provides a superior representation of the systemic musculoskeletal amyloid burden. Nuclear medicine physicians must adopt tracer-specific interpretive approaches to optimize non-invasive phenotyping. TRIAL REGISTRATION: not applicable.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Di Giorgio A, Battisti G, Bonazzi N, et al. The role of extracardiac radiotracer biodistribution in the evaluation of cardiac amyloidosis: a retrospective multicenter study on [99mTc]Tc-DPD and [99mTc]Tc-HMDP. Eur J Nucl Med Mol Imaging. 2026. PMID: 42909580. doi:10.1007/s00259-026-08153-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。